Key Documents
Anne Hilgendorff
Academic Appointments
- Postdoctoral Research fellow, Pediatrics
Contact Information
-
Academic Offices
Personal Information Email Tel (650) 723-8535Administrative Contact Michelle Fox Administrative Associate Email Tel Work (650) 723-8239
Professional Snapshot
Honors and Awards
- Scientific Award, GNPI (Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin) (2008)
- Investigator Award, Gesellschaft für Perinatologie (2005)
- Young Investigator Award, GNPI (Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin) (2003)
- Best Abstract Award, GTH (Gesellschaft für Thrombose und Hämostaseforschung) (2003)
Professional Education
| MD: | L.-Maximilian University, Munich, Pediatrics (2008) |
| Doctor of Medicine: | Justus Liebig Universitat, (2004) |
Faculty Advisor
Scientific Focus
Research Interests
Dr. Anne Hilgendorff joined Dr. Rabinovitch/Dr. Bland's group in May 2008 with a grant of the German Research Foundation (DFG).
Dr. Hilgendorff graduated from the Justus-Liebig University School of Medicine in Giessen, Germany with a degree of Doctor of Medicine. She completed her Residency in Pediatrics at the Justus-Liebig University in Giessen and the Ludwig-Maximilian University in Munich, Germany, and is currently pursuing a Fellowship in Neonatology at the Center of Perinatal Medicine Grosshadern, Ludwig-Maximilian University in Munich, Germany.
Dr. Hilgendorff finished her thesis in the Department of Cardiology, Internal Medicine at the Justus-Liebig University in Giessen in 2004 investigating the effect of HMG-CoA reductase inhibitors on the coagulation system in heart transplant recipients in vitro and in vivo and pursued a study in pediatric heart transplant recipients regarding the indicative effect of adhesion molecule levels in rejection processes and transplant coronary artery disease. During her Residency in Pediatrics and following Fellowship in Neonatology Dr. Hilgendorff’s research focused on acute and chronic pulmonary adaptation in the term and preterm newborn infant. As well in clinical studies as in experimental approaches she investigated the role of surfactant proteins and further members of the innate immune system as well as markers of the inflammatory response in the injured newborn lung. As an investigator of the Giessen Research Center in Infectious Diseases, part of the Human Genome Network, she studied preterm infants suffering from early-onset sepsis and respiratory distress syndrome in genetic association studies and non-hypothesis thriven approaches using micro-array chip technology.
As part of her actual grant she is investigating changes in gene expression and lung morphology following long-term mechanical ventilation in transgenic and non-transgenic newborn mice.
Publications
- Association of polymorphisms in the human surfactant protein-D (SFTPD) gene and postnatal pulmonary adaptation in the preterm infant. Acta Paediatr. 2009; (1): 112-7
- Drug utilisation in very preterm infants: any changes during the past decade? Klin Padiatr. 2008 Jul-Aug; (4): 238-42
- Surfactant replacement and open lung concept--comparison of two treatment strategies in an experimental model of neonatal ARDS. BMC Pulm Med. 2008: 10
- Impact of airway obstruction on lung function in very preterm infants at term. Pediatr Crit Care Med. 2008; (6): 629-35
- Association of polymorphisms in the mannose-binding lectin gene and pulmonary morbidity in preterm infants. Genes Immun. 2007; (8): 671-7
Help